Science for Life Laboratory is a collaboration between four universities in Stockholm and
Uppsala: Stockholm University, Karolinska Institutet, KTH Royal Institute of Technology and Uppsala
University. The centre combines advanced technical know-how and state-of-the-art equipment with a broad knowledge in translational medicine and molecular bioscience. SciLifeLab currently employs around 1000 people, involving platform activities and research in biology, medicine and environmental sciences. The National Genomics Infrastructure (NGI) is a technology platform at SciLifeLab and is one of the most competitive genomics platforms in Europe. It is located in at the SciLifeLab Stockholm and Uppsala campuses. The NGI is appointed the national platform for massively parallel sequencing and genotyping by the Swedish research council. NGI Stockholm run its activities based on 1 NovaSeq, 3 HiSeq 2500, 5 HiSeq XTen, 2 MiSeq, and 2 Oxford Nanopore instruments. NGI Stockholm staff consists of approximately 27 FTEs (60% PhDs) is run in accordance with the accreditation provided by SWEDAC. During 2017 more than 32,000 samples were handled with applications in all fields of life sciences such as de novo genome sequencing, WGS re-sequencing, and RNA sequencing. In conjugation to the activities at NGI novel applications are developed by the KTH research group at SciLifeLab focusing on development of spatial in situ technologies such as spatial transcriptomics with broad applications in research and clinical routine.